Sergio Lociuro

1.7k total citations
37 papers, 1.3k citations indexed

About

Sergio Lociuro is a scholar working on Molecular Medicine, Molecular Biology and Pharmacology. According to data from OpenAlex, Sergio Lociuro has authored 37 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Medicine, 14 papers in Molecular Biology and 10 papers in Pharmacology. Recurrent topics in Sergio Lociuro's work include Antibiotic Resistance in Bacteria (15 papers), Pneumocystis jirovecii pneumonia detection and treatment (8 papers) and Antimicrobial Resistance in Staphylococcus (6 papers). Sergio Lociuro is often cited by papers focused on Antibiotic Resistance in Bacteria (15 papers), Pneumocystis jirovecii pneumonia detection and treatment (8 papers) and Antimicrobial Resistance in Staphylococcus (6 papers). Sergio Lociuro collaborates with scholars based in Switzerland, United States and United Kingdom. Sergio Lociuro's co-authors include Khalid Islam, Stephen Hawser, Paolo Tavecchia, Enrico Selva, Glenn E. Dale, Vincent Trebosc, Christian Kemmer, Heike Laue, Marc Gitzinger and Luigi Colombo and has published in prestigious journals such as Nature Communications, Biochemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Sergio Lociuro

35 papers receiving 1.2k citations

Peers

Countries citing papers authored by Sergio Lociuro

Since Specialization

Citations

This map shows the geographic impact of Sergio Lociuro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergio Lociuro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergio Lociuro more than expected).

Fields of papers citing papers by Sergio Lociuro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sergio Lociuro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergio Lociuro. The network helps show where Sergio Lociuro may publish in the future.

Co-authorship network of co-authors of Sergio Lociuro

This figure shows the co-authorship network connecting the top 25 collaborators of Sergio Lociuro. A scholar is included among the top collaborators of Sergio Lociuro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sergio Lociuro. Sergio Lociuro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Structure-activity relationships of actively FhuE transported rifabutin derivatives with potent activity against Acinetobacter baumannii 2023 ·European Journal of Medicinal Chemistry ·(unknown), Marilyne Bourotte, (unknown), (unknown), (unknown), (unknown), Marc Gitzinger, Christian Kemmer, Glenn E. Dale, (unknown), Sergio Lociuro, Mark Brönstrup, Nicolas Willand, Vincent Trebosc	4
2	Targeting virulence regulation to disarm Acinetobacter baumannii pathogenesis 2022 ·Virulence ·Vincent Trebosc, (unknown), Mohit Narwal, (unknown), (unknown), (unknown), (unknown), Marilyne Bourotte, Daniel Frey, Jürgen Grünberg, Andrej Trauner, Livia Ferrari, Antonio Felici, Olivia L. Champion, Marc Gitzinger, Sergio Lociuro, Richard A. Kammerer, Christian Kemmer, Michel Pieren	7
3	Design and synthesis of water-soluble prodrugs of rifabutin for intraveneous administration 2022 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), Vincent Trebosc, Marc Gitzinger, Benoît Déprez, (unknown), Glenn E. Dale, Marilyne Bourotte, Sergio Lociuro, Nicolas Willand	6
4	The Role of OmpR in Bile Tolerance and Pathogenesis of Adherent-Invasive Escherichia coli 2021 ·Frontiers in Microbiology ·(unknown), Adeline Sivignon, Michel Pieren, Marc Gitzinger, Sergio Lociuro, Nicolas Barnich, Christian Kemmer, Vincent Trebosc	12
5	Rifabutin for infusion (BV100) for the treatment of severe carbapenem-resistant Acinetobacter baumannii infections 2021 ·Drug Discovery Today ·Vincent Trebosc, Christian Kemmer, Sergio Lociuro, Marc Gitzinger, Glenn E. Dale	15
6	An amphipathic peptide with antibiotic activity against multidrug-resistant Gram-negative bacteria 2020 ·Nature Communications ·Alysha G. Elliott, Johnny X. Huang, Søren Neve, Johannes Zuegg, Ingrid A. Edwards, Amy K. Cain, Christine J. Boinett, Lars Barquist, Carina Vingsbo Lundberg, Jason A. Steen, Mark S. Butler, Mehdi Mobli, (unknown), Mark A. T. Blaskovich, Sergio Lociuro, Magnus Strandh, Matthew A. Cooper	142
7	A nutrient-limited screen unmasks rifabutin hyperactivity for extensively drug-resistant Acinetobacter baumannii 2020 ·Nature Microbiology ·Brian Luna, Vincent Trebosc, (unknown), Malina A. Bakowski, (unknown), Jun Yan, (unknown), Jiaqi Cheng, Travis B. Nielsen, Ju‐Hyeon Lim, (unknown), Hyungjin Eoh, Case W. McNamara, Nicholas Skandalis, Rosemary C. She, Christian Kemmer, Sergio Lociuro, Glenn E. Dale, Brad Spellberg	53
8	A microdose study of 14C-AR-709 in healthy men: pharmacokinetics, absolute bioavailability and concentrations in key compartments of the lung 2013 ·European Journal of Clinical Pharmacology ·Graham Lappin, Malcolm Boyce, (unknown), Sergio Lociuro, Mark Seymour, Steve Warrington	13
9	4″-O-(ω-Quinolylamino-alkylamino)propionyl derivatives of selected macrolides with the activity against the key erythromycin resistant respiratory pathogens 2010 ·Bioorganic & Medicinal Chemistry ·(unknown), Hana Čipčić Paljetak, Gorjana Lazarevski, (unknown), Sulejman Alihodžić, (unknown), (unknown), Daniele Andreotti, Vitomir Šunjić, John M. Berge, Stjepan Mutak, Miljenko Dumić, Sergio Lociuro, David Holmes, (unknown), Vesna Eraković Haber, Radan Spaventi	26
10	Increased hydrophobic interactions of iclaprim with Staphylococcus aureus dihydrofolate reductase are responsible for the increase in affinity and antibacterial activity 2009 ·Journal of Antimicrobial Chemotherapy ·Christian Oefner, M. Bandera, Andreas Haldimann, Heike Laue, Henk Schulz, (unknown), Salvatore Parisi, (unknown), Sergio Lociuro, Glenn E. Dale	83
11	Inhibitory properties and X-ray crystallographic study of the binding of AR-101, AR-102 and iclaprim in ternary complexes with NADPH and dihydrofolate reductase fromStaphylococcus aureus 2009 ·Acta Crystallographica Section D Biological Crystallography ·Christian Oefner, Sandro Parisi, Henk Schulz, Sergio Lociuro, Glenn E. Dale	34
12	In vitro activity of the novel diaminopyrimidine, iclaprim, in combination with folate inhibitors and other antimicrobials with different mechanisms of action 2007 ·Journal of Antimicrobial Chemotherapy ·Heike Laue, (unknown), Andressa Bernardi, Stephen Hawser, Sergio Lociuro, Khalid Islam	30
13	Discovery of Highly Potent and Selective CXCR4 Inhibitors Using Protein Epitope Mimetics (PEM) Technology 2007 ·CHIMIA International Journal for Chemistry ·(unknown), John A. Robinson, Kerstin Moehle, Thomas Klimkait, François Hamy, Vincent Brondani, Sergio Lociuro, (unknown), Jan W. Vrijbloed, (unknown), Frank O. Gombert, (unknown), Jürg Zumbrunn, Reshmi Mukherjee, Bárbara Romagnoli, (unknown), Steven J. DeMarco, Daniel Obrecht	2
14	A novel ketolide class: Synthesis and antibacterial activity of a lead compound 2007 ·Bioorganic & Medicinal Chemistry Letters ·Daniele Andreotti, (unknown), Stefano Biondi, Daniele Donati, (unknown), Sergio Lociuro, Carla Marchioro, Alfonso Pozzan, Emiliangelo Ratti, Silvia Terreni	15
15	Effect of human plasma on the antimicrobial activity of iclaprim in vitro 2007 ·Journal of Antimicrobial Chemotherapy ·Heike Laue, (unknown), (unknown), Stephen Hawser, Sergio Lociuro, Khalid Islam	17
16	Discovery of novel, highly potent and selective β-hairpin mimetic CXCR4 inhibitors with excellent anti-HIV activity and pharmacokinetic profiles 2006 ·Bioorganic & Medicinal Chemistry ·Steven J. DeMarco, (unknown), (unknown), Kerstin Moehle, Reshmi Mukherjee, Bárbara Romagnoli, John A. Robinson, (unknown), Frank O. Gombert, Sergio Lociuro, (unknown), Jan W. Vrijbloed, Jürg Zumbrunn, (unknown), Daniel Obrecht, Vincent Brondani, François Hamy, Thomas Klimkait	65
17	Dihydrofolate reductase inhibitors as antibacterial agents 2005 ·Biochemical Pharmacology ·Stephen Hawser, Sergio Lociuro, Khalid Islam	260
18	SYNTHESIS AND ACTIVITY STUDIES ON 3-(CARBOXYALKYLTHIO)RIFAMYCIN S DERIVATIVES 1997 ·Gazzetta chimica italiana ·Luciano Cellai, (unknown), (unknown), (unknown), Luisa Mannina, A. Benedetto, Antonino Di, Sergio Lociuro, F Ripamonti	2
19	Antimicrobial Activities of Chemically Modified Thiazolyl Peptide Antibiotic MDL 62,879 (GE2270A). 1997 ·The Journal of Antibiotics ·Sergio Lociuro, Paolo Tavecchia, (unknown), Paolo Landini, Beth P. Goldstein, Maurizio Denaro, Romeo Ciabatti	10
20	Analysis of madurose and other actinomycete whole cell sugars by gas chromatography 1991 ·Journal of Microbiological Methods ·(unknown), Paolo Tavecchia, Sergio Lociuro, Margherita Zanol, Luigi Colombo, Enrico Selva	103

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact